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Minnesota, Minneapolis, MinnesotaABSTRACT We investigated a model of acute respiratory distress syndrome in which the serum protein albumin adsorbs to an
air-liquid interface and prevents the thermodynamically preferable adsorption of the clinical lung surfactant Survanta by inducing
steric and electrostatic energy barriers analogous to those that prevent colloidal aggregation. Chitosan and polyethylene glycol
(PEG), two polymers that traditionally have been used to aggregate colloids, both allow Survanta to quantitatively displace
albumin from the interface, but through two distinct mechanisms. Direct visualization with confocal microscopy shows that
the polycation chitosan coadsorbs to interfacial layers of both Survanta and albumin, and also colocalizes with the anionic
domains of Survanta at the air-liquid interface, consistent with it eliminating the electrostatic repulsion by neutralizing the surface
charges on albumin and Survanta. In contrast, the PEG distribution does not change during the displacement of albumin by
Survanta, consistent with PEG inducing a depletion attraction sufficient to overcome the repulsive energy barrier toward
adsorption.INTRODUCTIONLung surfactant (LS) is a mixture of lipids and proteins that
lowers the surface tension at the air-liquid interface of the
epithelial fluid in the millions of alveoli in the lungs. LS
allows for proper respiration by minimizing the work of
inhalation and preventing alveolar collapse upon exhalation
(1). A disruption in the normal function of LS contributes to
acute respiratory distress syndrome (ARDS), which is char-
acterized by a rapid onset of respiratory failure (2) and
affects 150,000 people annually in the United States with
40% mortality (2–4). Although the pathogenesis of ARDS
is not fully understood, a contributing factor is the inactiva-
tion of LS by serum proteins, such as albumin, that leak into
the lungs as a result of increased permeability of the alveolar
capillaries caused by another underlying disease or trauma
(2,4,5). Concentrations of albumin and other serum proteins
in the alveolar fluid are elevated during ARDS (6), and an
ARDS-like decrease in LS performance occurs both in
animal models (5) and in vitro when serum proteins are
present at these abnormally high concentrations (4,7–10).
Many serum proteins are surface active and thus compete
with LS to occupy the alveolar air-liquid interface (7–9,11),
but do not sufficiently reduce surface tension in the lungs for
respiration. Albumin, the most prevalent serum protein,
spontaneously adsorbs to the air-liquid interface and in-
creases the surface pressure to (i.e., reduces the surface
tension by) 20–25 mN/m (7,9). Because albumin is soluble
in the alveolar fluid, interfacial albumin molecules desorb
during exhalation as the interfacial area decreases, and the
remaining molecules on the interface do not pack tightlySubmitted July 20, 2011, and accepted for publication January 9, 2012.
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0006-3495/12/02/0777/10 $2.00enough to reach the high surface pressures necessary for
respiration (4,7–10). In comparison, LS adsorbs to an equi-
librium surface pressure of 45–50 mN/m (8) and does
not desorb from the interface with decreasing surface area.
Therefore, LS forms a tightly packed interfacial mono-
layer that achieves a maximum surface pressure of 65–
70 mN/m (sufficient for respiration) due to collapse of the
monolayer (12) rather than desorption of surfactant from
the interface.
Equilibrium thermodynamics predicts that a LS film
should always displace an albumin film at an air-liquid in-
terface because LS lowers the surface energy more than
albumin (by 45–50 versus 20–25 mJ/m2) (9). However,
this thermodynamically favorable replacement is kinetically
limited and may not occur for hours or more (4,8,9,13,14).
Albumin (diameter ~10 nm) diffuses ~1000-fold faster
than the larger LS aggregates (diameter ~10 mm) because
the diffusion coefficient for spherical particles is inversely
proportional to diameter. As a result, albumin reaches the
newly created air-liquid interface more rapidly than LS
during inhalation. Once at the interface, the negatively
charged albumin (15) induces a repulsive energy barrier
(16–18) that prevents LS, which is also negatively charged
(19), from reaching the interface (Fig. 1 A). This kineti-
cally hindered equilibrium shares many features with the
Derjaguin-Landau-Verwey-Overbeek (DLVO) theory of
colloid stability (9,16–18). Colloidal dispersions do not
reach equilibrium (i.e., aggregate) for years if the energy
barrier toward aggregation is sufficiently high.
Oppositely charged polyelectrolytes promote aggregation
of charged colloids and also enhance surfactant adsorp-
tion in the presence of albumin and other serum proteins
by reducing electrostatic repulsions (20,21). The DLVOdoi: 10.1016/j.bpj.2012.01.014
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FIGURE 1 Schematic diagrams of albumin inhibition of the clinical LS
Survanta and two distinct mechanisms of polymer-enhanced Survanta
adsorption. (A) Albumin-inhibited diffusion of Survanta to the interface.
The negative charges on albumin and Survanta create an electrostatic
barrier that prevents Survanta from reaching the interface (Eq. 1). (B)
Polycationic chitosan binds to the negative charges on albumin and
Survanta, and reduces the magnitude of the electrostatic barrier toward
Survanta diffusion to the interface, which allows Survanta to replace the
interfacial film of albumin. (C) PEG is physically excluded from approach-
ing the interface, albumin, or Survanta aggregates within the radius of gyra-
tion of PEG (dotted regions). When these excluded volumes overlap, PEG
cannot enter the gap between the Survanta aggregates and the interface (or
between aggregates), which leads to an osmotic pressure that pushes the
aggregates toward the interface or each other. This is equivalent to
increasing the volume available to PEG, which is an entropically favorable
process (Eq. 2).
778 Shieh et al.potential combines repulsive double-layer electrostatic
forces with attractive van der Waals interactions to explain
the stability of charged colloidal suspensions and the inhibi-
tion of LS adsorption by albumin. Between two spheres
of radius, a, at separation, r, surface potential, js, bulk ion
concentration, ni, of valence, zi, and Debye length,
k1 ¼ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃðεε0kTÞ=ðe2Piz2i niÞp , the DLVO potential, FDLVO,
is (18):
FDLVO ¼ 32pεε0

kT
ez
2
a tanh2

ezjs
4kT

 expð  kðr  2aÞÞ  aAH
12ðr  2aÞ;
(1)
where AH is the Hamaker constant that determines the
magnitude of the attractive forces, ε is the dielectric con-
stant, ε0 is the vacuum permittivity, e is the elementary
charge, k is the Boltzmann constant, T is the absolute
temperature, and z is the valency of the electrolyte counter-
ions. The surface potential, js, affects the magnitude of the
repulsive electrostatic forces and is proportional to theBiophysical Journal 102(4) 777–786surface charge density, s, of albumin or LS (16–18). The
surface charge density is set by the pK values of the amino
acids in albumin or the charged lipids in LS (both albumin
and LS are negatively charged at neutral pH). The extent
of dissociation of the charged surface groups of albumin
and LS also depends on the pH and total electrolyte concen-
tration of the subphase liquid (22). The linear and polyca-
tionic polysaccharide chitosan (20,21,23,24) reduces s,
and hence js, by binding to the anionic groups on albumin
and/or LS, which reduces the electrostatic repulsion and
lowers the energy barrier toward LS adsorption (Fig. 1 B).
Rather than reducing the electrostatic repulsion between
colloids (or albumin and LS), nonadsorbing polymers in-
duce an attractive interaction that can cause colloidal aggre-
gation or adsorption of LS. Polyethylene glycol (PEG) and
dextran increase adsorption of LS to an albumin-covered
air-liquid interface (8,13,25–27) and improve oxygenation
in animals with lung injuries when added to LS (28–30).
These neutral polymers do not change the surface charge
density, surface potential, or Debye length in Eq. 1, but
instead induce a depletion-attraction potential that reduces
the net repulsive potential. If LS particles of radius, a,
immersed in a polymer solution of volume fraction, fp,
approach the interface more closely than the effective poly-
mer diameter, 2 Rg, the polymer can no longer fit into the
excluded volume between the sphere and the interface
(14,31,32). The polymer concentration is reduced in the
excluded volume, resulting in a lower osmotic pressure.
Consequently, the osmotic pressure on the large sphere
becomes unbalanced, leading to a depletion-attraction force
that pushes the LS particle toward the interface (14,31,32):
Fdep ¼ 3fpkT
a
Rg

1 r
2Rg
2
: (2)
Simply adding Fdep to FDLVO in Eq. 1 to account for the
presence of nonadsorbing polymers in solution reduces the
net repulsive potential and promotes LS adsorption (Fig. 1
C). However, to induce a depletion attraction, the polymer
must remain homogeneously distributed in solution and
not adsorb to the interface, LS, or albumin.
The two distinct mechanisms of electrostatic neutraliza-
tion and depletion attraction for promoting LS adsorption
in the presence of an inhibitory interfacial albumin film
result in two distinct polymer distributions. Here, we used
confocal fluorescence microscopy to determine the three-
dimensional distributions of fluorescently labeled LS,
albumin, chitosan, and PEG in the vicinity of the air-liquid
interface. We present evidence that 1), an albumin film pre-
vents the clinical LS Survanta from adsorbing to the air-
liquid interface; 2), the polycation chitosan adsorbs to
both albumin and Survanta, decreases their surface charges
and electrostatic repulsion, and thereby promotes the quan-
titative exchange of albumin with Survanta at the inter-
face; and 3) the neutral, hydrophilic PEG also promotes
Restoring Lung Surfactant Function 779exchange of albumin with Survanta, but through an attrac-
tive depletion-attraction mechanism in which the distribu-
tion of PEG in solution and at the interface does not change.MATERIALS AND METHODS
Surfactants and subphase
Bovine serum albumin, PEG (10 kDa), and 75–85% deacetylated chitosan
(50–190 kDa) were obtained from Sigma-Aldrich (St. Louis, MO).
Chitosan is a linear polysaccharide composed of units of N-acetyl-
D-glucosamine and its deacetylated counterpart, D-glucosamine, whose
amino groups become protonated under neutral to acidic conditions. A
Milli-Q Gradient A10 system (Millipore, Billerica, MA) provided ultrapure
water with a resistivity of at least 18.0 MU$cm. MOPS-buffered saline
(150 mM NaCl, 2 mM CaCl2, 1 mM 3-(N-morpholino)propanesulfonic
acid, pH 7.0) was used to prepare the aqueous subphase. Albumin and
PEG were prepared as stock solutions in the MOPS-buffered saline, and
the chitosan was dissolved in 150 mM NaCl with 1% acetic acid. Bovine
serum albumin labeled with Texas Red (TR-albumin; Invitrogen, Carlsbad,
CA) and 10-kDa PEG conjugated to fluorescein isothiocyanate (FITC-PEG;
Nanocs, New York, NY) were prepared as solutions in 150 mM NaCl.
Dipalmitoylphosphatidylethanolamine with Texas Red (TR-DPPE) conju-
gated to the headgroup was purchased from Invitrogen. Survanta (Abbott
Nutrition, Columbus, OH) was generously provided by the Santa Barbara
Cottage Hospital neonatal intensive care unit. Survanta, a clinically used
replacement LS, is an organic extract of minced bovine lungs fortified
with dipalmitoylphosphatidylcholine (DPPC), palmitic acid, and tripalmi-
tin. We prepared samples of Survanta by diluting it from 25 mg/mL to
2 mg/mL in 150 mM NaCl. Each sample was sonicated for 30 s to ensure
proper mixing and to break up flocculates, and stored at 4C. Before use, the
diluted Survanta was returned to room temperature and vortexed. Immedi-
ately before each experiment, we premixed a fresh 120 mL subphase in
glass using the appropriate stock solutions and MOPS-buffered saline. Sub-
phases containing chitosan were adjusted to pH 6.8–7.0 with 1 M NaOH. A
total of 1 mg of Survanta and subphase concentrations of 2 mg/mL albumin,
25 mg/mL chitosan, and 30 mg/mL PEG were used in this work unless
otherwise noted.Fluorescently labeled chitosan
Chitosan was fluorescently labeled (AF-chitosan) with Alexa Fluor 488
carboxylic acid succinimidyl ester (Invitrogen). The chitosan was incubated
in 10 mM sodium acetate buffer (pH 7.0) with the fluorescent dye added in
dimethyl formamide at a volume ratio of 1:20 (dimethyl formamide/buffer)
to a final molar ratio of 1:1 (dye/chitosan). The mixture was incubated
at 37C with shaking for 2 h, followed by dialysis of the sample for 48 h
against 10 mM HCl to remove unbound dye. The degree of chitosan
labeling was found to be ~1:120 (mol dye/mol chitosan) as estimated by
gravimetric analysis and absorption spectroscopy of the dye conjugate at
495 nm in 200 mM sodium acetate buffer (pH 2.7) assuming a molar extinc-
tion coefficient of 71,000 cm1$M1 (33). An average molecular mass for
chitosan of 120 kDa was used for all calculations.Surface balance measurements
We performed experiments using a custom-milled Teflon Langmuir trough
with continuous steel ribbon barriers. We measured surface pressure (i.e.,
the reduction in surface tension of a clean air-water interface, 72 mN/m
at 25C) using a filter paper Wilhelmy plate tensiometer (Riegler and
Kirstein, Germany). Interfacial temperature was measured with a miniature
infrared thermocouple (Omega Engineering, Stamford, CT) and controlled
at 25C via a circulating water bath. All experiments were conducted at102(4) 777–78625C, rather than 37C, to reduce convection and evaporation that disrupted
image acquisition. Although this is below physiological temperature, the
phase behavior of Survanta remains similar over the range of 20–37C
(34). Additionally, both the DLVO potential (Eq. 1) and the depletion attrac-
tion (Eq. 2) do not change significantly over this temperature range (18). A
custom-milled Delrin cover limited evaporation to negligible levels. A
custom computer interface written in LabVIEW 9.0 (National Instruments,
Austin, TX) handled all aspects of trough control and data collection.
We deposited the aqueous Survanta suspension into the Langmuir trough
dropwise by using a glass microsyringe and touching each drop to the air-
liquid interface. Although some of the Survanta was immediately deposited
on the interface, most of it went into the aqueous subphase and then
adsorbed to the interface. After a 20-min period to allow for this adsorption
to occur, the trough was cycled eight times from a maximum area of
145 cm2 to a minimum area of 50 cm2 at a rate of 20 cm2/min.Laser scanning confocal fluorescence
microscopy
We used a C1 confocal scan head fitted on a Nikon Eclipse 80i upright
microscope (Nikon Instruments, Melville, NY) with a Nikon plan apochro-
matic 20 air immersion objective with a working distance of 1 mm,
0.75 NA, and correction for a 170 mm glass coverslip. A 12-mm-diameter,
170-mm-thick, round glass coverslip was attached to the tip of the objective
to minimize spherical aberration due to refractive index mismatch (35). The
objective was resistively heated to 35C to minimize condensation. Fluores-
cence contrast was provided by small amounts of dye-conjugated compo-
nents. Concentrations of 5 mg/mL AF-chitosan, 15 mg/mL FITC-PEG,
and 10 mg/mL TR-albumin were added with appropriate amounts of the
unlabeled species during subphase preparation. Survanta samples were
doped with 1 wt% TR-DPPE (as a suspension in ultrapure water) during
dilution and before sonication.
At a given surface pressure or surface area, the trough barriers were
paused and a series (z-stack) of images was acquired from 7 mm above
to 10 mm below the air-liquid interface at 0.5 mm intervals. The imaging
plane was oriented parallel to the air-liquid interface in the Langmuir
trough. Each image required ~1 s to raster scan across 512  512 pixels
representing 150  150 mm. It took 40 s to acquire a complete z-stack,
and the surface pressure remained effectively constant (52 mN/m maxi-
mum deviation) during acquisition. The sample was excited by both
488 nm and 594 nm lasers to allow for simultaneous visualization of two
fluorophores. We acquired the z-stacks starting at the second compression
cycle after adding the subphase to the trough and/or starting at the fourth
compression cycle after depositing Survanta into the subphase.
To characterize interfacial phenomena in the Langmuir trough, we used
conventional images of the air-liquid interface extracted from the image
stack as well as axial fluorescence intensity profiles calculated from the
z-stack. To calculate an axial intensity profile, the pixel fluorescence inten-
sity for each image slice was averaged, normalized to the maximum
intensity of all slices in the z-stack, and plotted as a function of the axial
position.Deconvolution methodology
The measured signal in an optical system is the convolution of the micro-
scope point-spread function (PSF) with the true image of the sample
(35). To determine the PSF, we measured the axial fluorescence profile of
a fluorescently labeled DPPC monolayer (see Fig. 3 A). The 3-nm-thick
monolayer effectively represents a d-function in fluorescence intensity;
the convolution between the PSF and the d-function equals the PSF, so
the measured profile of the DPPC monolayer represents the microscope
PSF. To form the monolayer, 20 mg of DPPC (Avanti Polar Lipids,
Alabaster, AL) doped with 0.5 wt% TR-DPPE in a 2 mg/mL chloroform
solution were spread dropwise onto a subphase of 120 mL of ultrapure
780 Shieh et al.water at 25C. Z-stacks were acquired at surface pressures ranging from 5
to 60 mN/m. The resulting fluorescence profiles were averaged and linearly
interpolated at 10 nm intervals to determine the PSF for the optical system.
We then convolved this experimentally acquired PSF with appropriate input
models using a discrete convolution algorithm to best match the measured
axial fluorescence profiles for Survanta, albumin, chitosan, and PEG.Colocalization of material
We quantified the degree of lateral colocalization between red (i.e.,
Survanta) and green (i.e., chitosan or PEG) fluorescence using the Pearson’s
colocalization coefficient, rp (35):
rp ¼
P
i

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
Gi  Gavg

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where Ri and Gi are the red and green intensities, respectively, of pixel i,
and Ravg and Gavg are the red and green intensities, respectively, averaged
over the whole image.RESULTS
Reversing the albumin-induced inactivation
of Survanta
Compression-expansion isotherms for Survanta deposited
on a physiological saline subphase, with or without albumin,
demonstrated normal (no albumin) and inhibited (with
albumin) LS function (Fig. 2 A). In the absence of albumin,
Survanta reached surface pressures > 65 mN/m when com-
pressed to mimic the change in alveolar area upon exhala-
tion. During expansion, the surface pressure decreased
rapidly and demonstrated the characteristic hysteresis of
normal LS (34). However, when Survanta was deposited
on a subphase containing albumin to mimic ARDS-like
conditions (4,6,9), the surface pressure did not increase
during compression. Instead, the isotherm matched that of
albumin alone. This indicates that Survanta did not reach
the interface in sufficient quantity to substantially raise the
surface pressure because of the electrostatic energy barrier
toward adsorption induced by the interfacial albumin film
(Fig. 1 A) (13).A CB
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added to subphases containing albumin and a series of PEG concentrations. Incr
Biophysical Journal 102(4) 777–786Adding either chitosan (Fig. 2 B) or PEG (Fig. 2 C) to the
subphase reversed the inhibitory effects of albumin. An
optimal chitosan concentration of 25–50 mg/mL restored
the maximum surface pressure to ~65 mN/m, whereas 100
mg/mL of chitosan was not as effective and the maximum
surface pressure dropped. A substantially higher concentra-
tion of PEG (30 mg/mL) in the albumin-containing sub-
phase restored the characteristic features of the Survanta
isotherm, as indicated by the maximum surface pressure
increasing to ~70 mN/m. The shift of the compression curve
toward larger trough areas with increasing concentrations of
PEG was consistent with increasing surface concentrations
of Survanta (13). Of interest, the optimum concentration
of chitosan was 1000-fold lower than that of PEG, and inhi-
bition returned with higher than optimal amounts of chito-
san. These observations suggest that chitosan neutralized
the negative surface charges of albumin and Survanta
(Fig. 1 B and Eq. 1) and then overcompensated for them,
whereas the neutral PEG induced a depletion attraction pro-
portional to the PEG volume fraction (Fig. 1 C and Eq. 2).Axial fluorescence distributions
Three distinct axial fluorescence intensity profiles resulted
from Survanta (Fig. 3 B), albumin (Fig. 3 C), and either
chitosan or PEG (Fig. 3 D) as single components in the
Langmuir trough. The measured fluorescence intensities
(symbols) were fit (solid curves) to a convolution of the
true fluorescence profiles (dotted lines) and the microscope
PSF, as determined using a solvent-spread DPPC mono-
layer (Fig. 3 A) (35). The fluorescence intensity profile for
Survanta had a Gaussian-like shape (Fig. 3 B), which was
similar to but wider than that of the DPPC monolayer.
The Survanta profile indicated a high concentration at the
air-liquid interface and negligible concentration elsewhere,
as expected for an insoluble, multilayered surfactant film
(13,34) at the air-liquid interface. Albumin, a soluble surfac-
tant, had an asymmetric fluorescence intensity profile (Fig. 3
C) consistent with a high interfacial concentration and a
uniform subphase concentration. The albumin concentrationFIGURE 2 Third-cycle isotherms at 25C
demonstrate the normal, inhibited, and polymer-
restored activity of Survanta. (A) Survanta (dotted
line) deposited dropwise in a physiological, buff-
ered-saline subphase. The maximum surface pres-
sure was> 65 mN/m (surface tension< 10 mN/m)
upon compression, with significant hysteresis upon
expansion. For a subphase containing albumin
(dashed line), there were minimal changes in sur-
face pressure with changes in interfacial area, con-
sistent with the expected desorption-adsorption
behavior of the soluble, surface-active albumin.
When Survanta was added to a subphase containing
albumin (Survantaþ albumin, solid black line), the
ntaining albumin and a series of chitosan concentrations. Increasing chitosan
rvanta to adsorb and themaximum surface pressure to decrease. (C) Survanta
easing the PEG concentration restored the normal Survanta isotherm.
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FIGURE 3 Axial fluorescence intensity profiles
measured via confocal microscopy. (A) Solvent-
spread DPPC monolayer at the air-water interface
representing a d-function in fluorescence intensity
used to measure the microscope PSF. The solid
lines in (B–D) represent the convolution of the
proposed concentration profiles (dotted lines)
with the PSF experimentally measured in (A). (B)
Fluorescence intensity profile of Survanta on
a buffered-saline subphase. (C) Fluorescence
intensity profile of albumin in a buffered-saline
subphase. (D) Fluorescence intensity profile of
either chitosan or PEG in a buffered-saline
subphase. Profiles were calculated from z-stacks
acquired at a surface pressure of 35 mN/m (B) or
a fixed trough surface area of 115 cm2 (C and
D). Negative axial locations represent the air, posi-
tive locations correspond to the aqueous subphase,
and the air-liquid interface is at zero.
Restoring Lung Surfactant Function 781profile was consistent with x-ray reflectivity measurements
showing a densely packed layer of albumin alongside
a less dense second layer with an approximate total thick-
ness of 10 nm at the air-liquid interface (27). Both chitosan
and PEG showed sigmoidal fluorescence intensity profiles
with no interfacial peak (Fig. 3 D), corresponding to
a step change in concentration at the interface with no
surface activity. Adding either chitosan or PEG to the
subphase did not significantly change the surface pressure,
consistent with the lack of surface activity.
Although PEG and chitosan had identical axial distribu-
tions with no albumin or Survanta present, their distribu-
tions were distinctly different during inhibition reversal
with albumin and Survanta also in the Langmuir trough.
The sigmoidal fluorescence intensity profile of chitosan
changed considerably in the presence of an interfacial film
of albumin (Fig. 4 A). The chitosan profile almost identi-
cally matched that of albumin, including a peak in fluores-
cence intensity at the air-liquid interface. Chitosan likely
adsorbed to albumin both at the interface and in the bulk,
and neutralized the negative charges on the albumin. Addi-
tion of Survanta to the trough caused the albumin fluores-
cence intensity profile to change to a sigmoidal shape
(Fig. 4 B), which was consistent with a constant bulk con-
centration of albumin and no surface activity. Using fluores-
cently labeled Survanta, we were able to observe that102(4) 777–786Survanta quantitatively replaced the albumin at the interface
(Fig. 4 C). Chitosan remained at the interface with the
anionic Survanta film during this replacement process.
The axial fluorescence profile of PEG remained
sigmoidal, consistent with a constant subphase concentra-
tion and no surface activity, regardless of the presence
of albumin or Survanta. With no Survanta present, PEG
did not significantly affect the distribution of albumin
(Fig. 4 D). However, the addition of Survanta to the sub-
phase with PEG and albumin (Fig. 4 E) changed the albumin
fluorescence profile dramatically from a peak at the inter-
face to a sigmoidal profile, as was the case with chitosan
under similar conditions (Fig. 4 B). Again, Survanta
quantitatively replaced albumin at the air-liquid interface
(Fig. 4 F). The exchange of albumin with Survanta at the
interface did not alter the sigmoidal axial fluorescence
distribution of PEG, which indicated PEG was uniformly
distributed throughout the subphase as necessary for the
depletion-attraction mechanism.Lateral distributions of chitosan and PEG
We investigated the contrasting lateral distributions of chito-
san and PEG interacting with an interfacial Survanta film.
LS films are not laterally homogeneous, and instead form
domains in which the anionic lipids become segregated
No Survanta No Survanta
Unlabeled
Survanta
Unlabeled
Survanta
Unlabeled
Albumin
Unlabeled
Albumin
A
B
C F
E
D
FIGURE 4 Effects of albumin and Survanta on
the axial distributions of chitosan and PEG. (A
and B) Axial profiles of albumin and chitosan in
a buffered-saline subphase before (A) and after
(B) the addition of unlabeled Survanta. (C) Sur-
vanta on a buffered-saline subphase containing chi-
tosan and unlabeled albumin. (D and E) Albumin
and PEG in a buffered-saline subphase before (D)
and after (E) the addition of unlabeled Survanta.
(F) Survanta on a buffered-saline subphase con-
taining PEG and unlabeled albumin. Profiles were
calculated from z-stacks acquired at a surface pres-
sure of 35 mN/m (B, E, and F), a surface pressure
of 30 mN/m (C), or a fixed trough surface area of
115 cm2 (A and D). Negative axial locations repre-
sent the air, positive locations correspond to the
aqueous subphase, and the air-liquid interface is
at zero.
782 Shieh et al.(34,36,37). The shallow depth-of-field of the confocal micro-
scope resulted in a sharp delineation of the lateral distribution
of Survanta, chitosan, and PEG at the interface. Survanta
(Fig. 5A) exhibited a characteristicmottledmorphology con-
sisting of bright domains of a less ordered, liquid-expanded
(LE) phase in a continuous network of dark, more ordered,
liquid-condensed (LC) phase (27,34,36,37). Contrast in the
images resulted from the exclusion of the fluorescent lipid
used to label Survanta from the semicrystalline LC phase
and its inclusion in the LE phase (27,34,36,37), similar to
one or two component lipid monolayers (38). No lateral vari-
ations were observed for either chitosan (Fig. 5 B) or PEG
(Fig. 5 C) alone in the saline subphase.Biophysical Journal 102(4) 777–786In similarity to the axial distributions, the lateral distribu-
tion of chitosan correlated strongly with the domains in the
Survanta film, whereas PEG remained homogeneously dis-
tributed at the interface. High concentrations of chitosan
at the interface, indicated by the bright green regions
(Fig. 5 E), strongly correlated with the bright red LE do-
mains of Survanta (Fig. 5 D). The domains appeared bright
yellow in the combined image showing a high degree of
colocalization (Fig. 5 F). The observed association of the
polycationic chitosan with the LE, red phase of Survanta
confirmed earlier speculation that the anionic lipids in
Survanta primarily segregate into the LE phase (34,36,37).
The majority of anionic lipids in LS are unsaturated
FE H
I
D
B C
G
A
J
30 µm
Survanta only Chitosan only PEG only
Survanta channel Survanta channel
Chitosan channel PEG channel
Overlaid channels Overlaid channels
FIGURE 5 Lateral distribution of chitosan and PEG in relation to the
anionic domains of Survanta. (A–C) Individual materials in the Langmuir
trough with a buffered-saline subphase containing Survanta (A), chitosan
(B), or PEG (C). (D–F) Simultaneous visualization of red (Survanta) and
green (chitosan) fluorescence during inhibition reversal with Survanta on
a buffered-saline subphase containing chitosan and unlabeled albumin.
The mottled bright domains in a dark, continuous background in the
Survanta images resulted from lateral phase separation into a dye-rich,
LE phase and a dye-poor, LC phase, with the anionic lipids in Survanta
concentrated in the LE domains. Brighter red, multilayered regions within
the Survanta LE domains correlated most strongly with the brightest green
domains of chitosan to give the brightest yellow regions in the overlaid
image (arrows). (G–I) Simultaneous visualization of red (Survanta) and
green (PEG) fluorescence during inhibition reversal with Survanta on a buff-
ered-saline subphase containing PEG and unlabeled albumin. PEG showed
102(4) 777–786
Restoring Lung Surfactant Function 783phosphatidylglycerols (39). In general, unsaturated lipids
partition into the less-ordered LE phase (27,38,40). The
semicrystalline LC phase contains more of the saturated
phosphatidylcholine and fatty acids of Survanta (27,41).
In contrast to chitosan, there was no apparent interaction
between PEG and Survanta as PEG was uniformly laterally
distributed in the presence of an interfacial Survanta film
(Fig. 5, G–I). The colocalization of chitosan with the Sur-
vanta domains that contained the majority of the anionic
lipids, in contrast to the uniform lateral distribution of
PEG, indicates that chitosan neutralized the negatively
charged portions of the surfactant film whereas PEG
induced a depletion-attraction force.
Chitosan andPEGboth increased the average size of theLE
domains in the Survanta film (compare Fig. 5 A to Fig. 5, D
and G) with PEG causing a much larger size increase. PEG
may have induced the LE domains to coalesce and increase
in size through a lateral depletion-attraction force resulting
from the dehydration of the lipid headgroups (42,43). In
contrast, chitosan likely neutralized the anionic lipids within
the LE domains, which decreased the dipole density differ-
ence between the LE domains and continuous LC phase. As
a result, the energy of the LE domains decreased, which led
to an increase in the average domain size (38,44).Colocalization as a function of surface pressure
The Pearson’s colocalization coefficient (Eq. 3) was used to
quantify the overlap between the LE domains of Survanta
and either chitosan or PEG (Fig. 5 J). A value of þ1 meant
that the variance in the distribution of one color (e.g., chito-
san) correlated perfectly with the variance in the distribution
of another color (e.g., Survanta). A value of zero meant that
the variance in the distribution of one color (e.g., PEG) did
not correlate with the variance in the distribution of another
color (e.g., Survanta). As expected from the lateral images at
the air-liquid interface, the Pearson’s colocalization coeffi-
cient between PEG and Survanta was independent of surface
pressure and near zero in value. The lateral distribution of
PEG, like the axial distribution, was not altered by the pres-
ence of albumin or Survanta at any point in the compres-
sion-expansion cycle. However, the Pearson’s coefficient
between chitosan and Survanta increased with surface pres-
sure. The area per molecule in the monolayer decreased
with increasing surface pressure, which increased the lateral
density of the anionic lipids in the LE domains. At higher
surface pressures, the LE phase was squeezed out into multi-
layers (34). In the lateral images, the less intensely coloredno lateral structure or colocalization with the features of Survanta. (J)
Pearson’s colocalization coefficient, calculated using Eq. 3, as a function
of surface pressure for multiple trough compression-expansion cycles.
The scale bar in A applies to all images, which are displayed in a multi-
channel pseudocoloring scheme. The images were acquired at a surface
pressure of 35 mN/m (A and D–I) or a fixed trough surface area of
115 cm2 (B and C).
784 Shieh et al.areas corresponded to the LE monolayer domains, and the
brighter red areas highlighted by the arrows corresponded
to multilayer patches directly attached to the interface below
the LE domains (Fig. 5, D–F). A combination of the Sur-
vanta and chitosan channels (Fig. 5 F) showed that the areas
of strongest colocalization (i.e., brightest yellow) corre-
sponded to the brightest red regions of the Survanta film.
Upon expansion of the film, the colocalization coefficient
remained high until a surface pressure of ~20 mN/m was re-
ached, at which point the coefficient dropped back to the
value seen during compression (Fig. 5 J). We also observed
this critical respreading pressure in the isotherms (Fig. 2 C)
where the expansion curve flattened at ~20 mN/m, which
corresponded to Survanta multilayers starting to reincorpo-
rate into the monolayer (7).DISCUSSION
Our comparison of compression-expansion isotherms
shows a distinct difference between films of albumin and
Survanta at the interface (Fig. 2 A). Albumin behaves in a
typical manner for a soluble surfactant, in that its surface
pressure at a given subphase concentration remains rela-
tively constant regardless of the surface compression (7).
In contrast, the surface pressure of the insoluble Survanta in-
creases with compression until the film collapses at a much
higher surface pressure (34). With both albumin and Sur-
vanta in the Langmuir trough, the isotherm resembles that
of albumin only, which suggests that Survanta does not
reach the interface within an hour (9,13,27). However,
because the surface pressure, P, is the negative derivative
of the Gibbs free energy, G, with respect to the interfacial
area, A, at constant temperature, T: P ¼ ðvG=vAÞT , the
higher-surface-pressure Survanta should always displace
the lower-surface-pressure albumin at equilibrium. When
albumin occupies the air-liquid interface, Survanta in the
Langmuir trough clearly has no effect on the surface pres-
sure (Fig. 2 A), even with expansion and contraction of
the interface (7,9,13,27). This albumin-inhibited adsorption
of Survanta can also be visualized with three-dimensional
imaging of the air-liquid interface (see Fig. S1 in the Sup-
porting Material). In the lung, the time per breath is on
the order of seconds, so the hours-long delay of surfactant
adsorption to the interface would effectively prevent LS
from minimizing the work of breathing, which is consistent
with the surfactant inactivation associated with ARDS (4,5).
In the lungs of anARDS patient, and similarly in the Lang-
muir trough, abnormally high concentrations (2,5,6) of fast-
diffusing albumin rapidly saturate the alveolar air-liquid
interface, especially as new interface is generated during
the lung expansion of inhalation (8). The normally sponta-
neous adsorption of Survanta slows because albumin creates
an electrostatic barrier to the diffusion of Survanta to the
interface (Fig. 1 A). In the presence of an energy barrier,
the stability ratio, W, compares the actual flux of SurvantaBiophysical Journal 102(4) 777–786to the surface, J, with the uninhibited, diffusion-limited
flux, J0, and is proportional to the exponential of the
maximum,Fmax, of the DLVO potential (Eq. 1) (9,14,18,22):
W ¼ J0
J
f exp

Fmax
kT

: (4)
Decreasing Fmax restores equilibrium regardless of
whether that equilibrium results in the aggregation of
colloids or the exchange of albumin with Survanta at an
interface.
To reduce Fmax and restore surfactant adsorption, we
employed two common colloid flocculants: a polyelectrolyte
(i.e., chitosan) (24) of opposite charge to Survanta and albu-
min, and a nonadsorbing polymer (i.e., PEG) (31). The axial
fluorescence intensity profiles (Fig. 4) demonstrate that the
highly cationic chitosan adsorbs strongly to both the nega-
tively charged surfactant and albumin, neutralizing the
surface charge, s, and hence decreasing the magnitude of
the surface potential, js (Eq.1; the bulk concentration of chi-
tosan also reduces the Debye length, k1) (23,24). This
decreases Fmax and enhances surfactant diffusion to the
interface, which leads to a much faster equilibrium
exchange of albumin with Survanta at the air-liquid inter-
face (Figs. 4 and 5).
The subphase pH substantially affects (Eq. 1) the optimum
chitosan concentration for Survanta adsorption. Previous
researchers observed an optimal chitosan concentration of
1–5 mg/mL at pH 5.5 (21). Here, we investigated the effec-
tiveness of chitosan at pH 6.9 to better represent physiolog-
ical conditions, and found that the optimum chitosan
concentration increased to 25–50 mg/mL (Fig. 2 B). At pH
5.5, the net charge on albumin is3, and the cationic groups
on chitosan are ~90% dissociated (15,23,45). However, the
net charge on albumin increases to 8, whereas chitosan is
only ~30% dissociated at pH 6.9 (15,23,45). For Survanta,
the anionic lipids are primarily phosphatidylglycerols with
a pKa of 2.9 (46). Therefore, the surface charge of Survanta
does not change appreciably as pH increases from 5.5 to 6.9.
The increased negative charge of albumin suggests an equiv-
alent increase in s andjs (Eq. 1). Furthermore, the decreased
positive charge of chitosan means that charge neutralization
requires an eightfold higher chitosan concentration at pH 6.9
than at pH 5.5. Additionally, the decreased chitosan charge
density at higher pH also lowers the flocculation efficiency.
A suspension of charged latex colloids required ~30%
more chitosan to flocculate comparedwith the amount calcu-
lated by stoichiometric charge neutralization when the chito-
san charge density was similarly decreased (23). All of these
estimates predict a 10-fold increase in optimum chitosan
concentration at pH 6.9 compared with pH 5.5, which agrees
well with the observed increase.
Neutral and nonadsorbing PEG does not alter the electro-
static interaction between Survanta and albumin, but instead
generates a depletion-attraction potential (Eq. 2) that lowers
Restoring Lung Surfactant Function 785Fmax (Eq. 4) and promotes the equilibrium exchange of
albumin with Survanta at the interface. PEG induces an
unbalanced osmotic pressure on the Survanta particles that
enhances Survanta adsorption. Intrinsic to the depletion-
attraction mechanism is the lack of interaction between
PEG and either Survanta, albumin, or the interface. If
PEG adsorbed to the interface, to albumin, or to Survanta,
there would be no decrease in concentration in the gaps
between surfactant particles and the interface, and therefore
no depletion attraction. PEG remained uniformly distributed
in solution during the exchange of albumin with Survanta at
the interface (Figs. 4 and 5), which is consistent with the
assumed nonadsorbing behavior of PEG that allows it to
induce a depletion-attraction potential. To the best of our
knowledge, this is the first visualization of these funda-
mental features of the depletion attraction.
Although PEG and chitosan operate through two dis-
tinctly different mechanisms, the axial fluorescence intensity
profiles show that they both allowed for quantitative re-
placement of the low-surface-pressure albumin film with a
higher-surface-pressure Survanta film, as expected from
equilibrium thermodynamics. It has been suggested that
albumin coexists with interfacial films of surfactant (when
cospread at the air-liquid interface) to surface pressures
well beyond the equilibrium surface pressure of albumin,
and that this coexistence may be another mode of surfactant
inactivation during ARDS (47). Although this may be an
intermediate step in the exchange of albumin with Survanta
(27), especially at surface pressures < 25 mN/m, our results
are not consistent with albumin and Survanta coexisting or
mixing at the interface. At surface pressures > 30 mN/m,
the fluorescence intensity due to albumin at the interface
disappeared, and the albumin profile was consistent with
that of a uniform subphase concentration (compare Fig. 4,
A and D, to Fig. 4, B and E).
Direct visualization of Survanta adsorption in the pres-
ence of albumin demonstrates the close analogy between
colloid stability and the competitive adsorption of LS and
serum proteins. The same additives used to flocculate
colloids enhanced LS adsorption to the interface and pro-
moted a thermodynamically preferred exchange of the
inhibitory albumin film with LS. Using confocal micros-
copy, we demonstrated that the three-dimensional distribu-
tions of chitosan and PEG were consistent with two
distinct mechanisms: a charge neutralization mechanism
for chitosan, and a depletion-attraction mechanism for
PEG. Although chitosan was not surface-active by itself, it
coadsorbed with interfacial films of both Survanta and
albumin, colocalized with the anionic lipids in the Survanta
film, and also led to the quantitative exchange of albumin
with Survanta at the interface. The optimum concentration
of chitosan was pH-sensitive and determined by the degree
of dissociation (i.e., net charge) of chitosan, albumin, and
Survanta. In contrast, the distribution of PEG remained
unchanged in the presence of Survanta or albumin, although102(4) 777–786the induced depletion-attraction force quantitatively ex-
changed albumin with Survanta at the interface. Overall,
these results can be applied when competitive adsorption
must be controlled to reverse a kinetically hindered equilib-
rium. Finally, we should use our understanding of colloid
stability when engineering surfactant additives to promote
inhibition reversal in ARDS.SUPPORTING MATERIAL
A figure is available at http://www.biophysj.org/biophysj/supplemental/
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